Comparison of the incidence of new malignancies in diabetic patients in urban and rural populations in Poland in the years 2008-2014 based on the database of the National Health Fund.
Comparison of the incidence of new malignancies in diabetic patients in urban and rural populations in Poland in the years 2008-2014 based on the database of the National Health Fund. Arch Med Sci. 2019 Mar;15(2):330-336 Authors: Wierzba W, Śliwczynski A, Karnafel W, Dziemidok P, Pinkas J Abstract Introduction: Many epidemiological studies show a correlation between the risk of cancer and type 2 diabetes mellitus in various populations. Material and methods: The material was obtained from the database of the National Health Fund. This publication presents a comparison of the incidence of new malignancies in rural and urban populations of diabetic patients in Poland based on the database of the National Health Fund for the period between 1.05.2008 and 30.09.2014. Results: Comparison of the mean incidence of selected malignancies in diabetic patients in the population analysed indicated significant differences between the incidence rate in the urban and rural populations (p
Publication date: Available online 1 April 2020Source: Journal of Molecular LiquidsAuthor(s): Xianting Xie, Lu Zhang, Wenjuan Zhang, Reza Tayebee, Atefe Hoseininasr, Hamid H. Vatanpour, Zeinab Behjati, Suying Li, Marjan Nasrabadi, Liuyi Liu
Publication date: Available online 1 April 2020Source: Carbohydrate PolymersAuthor(s): Chia-Hsiang Yen, Sheng-Tien Li, Nai-Chen Cheng, You-Ren Ji, Jyh-Horng Wang, Tai-Horng Young
Publication date: Available online 1 April 2020Source: Inorganica Chimica ActaAuthor(s): Sourav De, S.K. Ashok Kumar
Publication date: Available online 1 April 2020Source: European Polymer JournalAuthor(s): Himani Kalita, Manoj Patowary
The coronavirus has been a far deadlier threat in New Orleans than the rest of the United States, with a per-capita death rate much higher than in New York City.Reuters Health Information
Conclusion: CD26 is involved in the pathogenesis of colorectal diseases; sCD26 is diminished in CRC patients suggesting the potential utility of a sCD26 for diagnosis. PMID: 32223519 [PubMed - as supplied by publisher]
Publication date: Available online 2 April 2020Source: Urology Case ReportsAuthor(s): Omar Karray, Ndiamoi Akassimadou, Stéphane Bart, Mihaela Cosma-Opris, Patrick Coloby, Walid Sleiman
Publication date: Available online 2 April 2020Source: Preventive MedicineAuthor(s): Francesca Holme, Jose Jeronimo, Francisco Maldonado, Claudia Camel, Manuel Sandoval, Benito Martinez-Granera, Mirna Montenegro, Jacqueline Figueroa, Rose Slavkovsky, Kerry A. Thomson, Silvia de Sanjose, the Scale-Up project team
Publication date: Available online 1 April 2020Source: Preventive MedicineAuthor(s): Shelton J. Bartley, Vicki Benard, Eric Tai, Tanner Rockwell, Kristy Kenney, Lisa C. Richardson
Two University of Rochester physicians — one as an investigator and one as a patient — had major roles in a cutting-edge clinical trial using the body’s own immune cells to fight late-stage cancer. The striking results, showing that 93 percent of the study patients responded to the treatment, were reported in the April 2, 2020, iss ue of New England Journal of Medicine.
More News: Biomedical Science | Bladder Cancer | Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Colorectal Cancer | Databases & Libraries | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Epidemiology | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | General Medicine | Kidney Cancer | Laryngeal Cancer | Leukemia | Liver | Lung Cancer | Melanoma | Myeloma | Neurology | Pancreas | Pancreatic Cancer | Poland Health | Prostate Cancer | Rural Health | Science | Skin | Skin Cancer | Study | Testicular Cancer | Urology & Nephrology